13389-88-3 Usage
Uses
Used in Pharmaceutical Industry:
TETRAHYDRO-5-OXO-2-PHENYLFURAN-3-CARBOXYLIC ACID is used as a pharmaceutical intermediate for the synthesis of various biologically active compounds. Its structural similarity to active molecules makes it a promising candidate for the development of new drugs.
Used in Organic Synthesis:
TETRAHYDRO-5-OXO-2-PHENYLFURAN-3-CARBOXYLIC ACID is used as a building block in organic synthesis for the preparation of various functionalized molecules. Its unique structure allows for the creation of a wide range of compounds with different properties and applications.
Used in Research and Development:
TETRAHYDRO-5-OXO-2-PHENYLFURAN-3-CARBOXYLIC ACID is used as a research compound to study its properties and potential applications in various fields, including drug discovery and development. Its unique structure and reactivity make it an interesting subject for scientific investigation.
Check Digit Verification of cas no
The CAS Registry Mumber 13389-88-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,3,8 and 9 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 13389-88:
(7*1)+(6*3)+(5*3)+(4*8)+(3*9)+(2*8)+(1*8)=123
123 % 10 = 3
So 13389-88-3 is a valid CAS Registry Number.
InChI:InChI=1/C11H10O4/c12-9-6-8(11(13)14)10(15-9)7-4-2-1-3-5-7/h1-5,8,10H,6H2,(H,13,14)
13389-88-3Relevant academic research and scientific papers
COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS
-
, (2010/10/03)
The present patent application relates to a cosmetic or dermatological composition comprising, in a cosmetically or dermatologically acceptable medium, a polymer comprising: (a) a polymer backbone that may be obtained by reaction: of a polyol comprising 3 to 6 hydroxyl groups;of a monocarboxylic acid containing 6 to 32 carbon atoms;of a polycarboxylic acid comprising at least two carboxylic groups COOH, and/or of a cyclic anhydride such as a polycarboxylic acid and/or of a lactone comprising at least one carboxylic group COOH; and(b) at least one junction group linked to the said polymer backbone and capable of establishing H bonds with one or more partner junction groups, each pairing of a junction group involving at least three H (hydrogen) bonds. The patent application also concerns a cosmetic treatment process using the said composition.
Compounds effective as cerebral schemia treating agents
-
, (2008/06/13)
1. A compound having the formula (I): STR1 wherein A is --CH2 --, --O--, or --S--; R1 is CH3 or OCH3 ; R2 is hydroxy of carboxy which may be optionally esterized or amidated; R3 is H or a l
